JPWO2021085554A1 - - Google Patents

Info

Publication number
JPWO2021085554A1
JPWO2021085554A1 JP2021553692A JP2021553692A JPWO2021085554A1 JP WO2021085554 A1 JPWO2021085554 A1 JP WO2021085554A1 JP 2021553692 A JP2021553692 A JP 2021553692A JP 2021553692 A JP2021553692 A JP 2021553692A JP WO2021085554 A1 JPWO2021085554 A1 JP WO2021085554A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021553692A
Other languages
Japanese (ja)
Other versions
JPWO2021085554A5 (cg-RX-API-DMAC7.html
JP7456643B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021085554A1 publication Critical patent/JPWO2021085554A1/ja
Publication of JPWO2021085554A5 publication Critical patent/JPWO2021085554A5/ja
Application granted granted Critical
Publication of JP7456643B2 publication Critical patent/JP7456643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2021553692A 2019-10-30 2020-10-29 核酸分子の製造方法、生体用材料、および生体用材料の製造方法 Active JP7456643B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/668,717 2019-10-30
US16/668,717 US11613748B2 (en) 2019-10-30 2019-10-30 Method for producing nucleic acid molecule, biomaterial, and method for producing biomaterial
JPPCT/JP2020/018142 2020-04-28
PCT/JP2020/018142 WO2021084782A1 (en) 2019-10-30 2020-04-28 Method for producing nucleic acid molecule, biomaterial, and method for producing biomaterial
PCT/JP2020/040687 WO2021085554A1 (ja) 2019-10-30 2020-10-29 核酸分子の製造方法、生体用材料、および生体用材料の製造方法

Publications (3)

Publication Number Publication Date
JPWO2021085554A1 true JPWO2021085554A1 (cg-RX-API-DMAC7.html) 2021-05-06
JPWO2021085554A5 JPWO2021085554A5 (cg-RX-API-DMAC7.html) 2022-07-07
JP7456643B2 JP7456643B2 (ja) 2024-03-27

Family

ID=75688434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553692A Active JP7456643B2 (ja) 2019-10-30 2020-10-29 核酸分子の製造方法、生体用材料、および生体用材料の製造方法

Country Status (3)

Country Link
US (2) US11613748B2 (cg-RX-API-DMAC7.html)
JP (1) JP7456643B2 (cg-RX-API-DMAC7.html)
WO (2) WO2021084782A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026015902A1 (en) * 2024-07-12 2026-01-15 The Regents Of The University Of California Synthetic matrix for stem cell encapsulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014128289A1 (en) * 2013-02-22 2014-08-28 Lumetti, Simone Biomedical device implantable in bone and/or cartilaginous tissue, and corresponding method to manufacture said biomedical device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014128289A1 (en) * 2013-02-22 2014-08-28 Lumetti, Simone Biomedical device implantable in bone and/or cartilaginous tissue, and corresponding method to manufacture said biomedical device

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ENAM S. F., ET AL.: "Enrichment of Endogenous Fractalkine and Anti-Inflammatory Cells via Aptamer-Functionalized Hydrogel", BIOMATERIALS, vol. 142, JPN6020050949, 10 July 2017 (2017-07-10), pages 52 - 61, XP085147120, ISSN: 0005139181, DOI: 10.1016/j.biomaterials.2017.07.013 *
森下裕貴: "2016年度実績報告書 機能性材料の開発を加速させる新規RNAアプタマー修飾医用材料の創出(研究課題/領", KAKENHI-PROJECT [ONLINE], JPN6020050945, 16 January 2018 (2018-01-16), ISSN: 0005139179 *
森下裕貴他: "血管内皮細胞増殖因子を特異的に補足するRNAアプタマー修飾材料の機能評価", 第39回日本バイオマテリアル学会大会予稿集, vol. 39, JPN6020050947, 13 November 2017 (2017-11-13), pages 157 - 1, ISSN: 0005139180 *

Also Published As

Publication number Publication date
US20220396792A1 (en) 2022-12-15
WO2021085554A1 (ja) 2021-05-06
WO2021084782A1 (en) 2021-05-06
JP7456643B2 (ja) 2024-03-27
US12595480B2 (en) 2026-04-07
US11613748B2 (en) 2023-03-28
US20210130820A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
BR112019017762A2 (cg-RX-API-DMAC7.html)
BR112019016141A2 (cg-RX-API-DMAC7.html)
AU2020104490A5 (cg-RX-API-DMAC7.html)
BR112021013944A2 (cg-RX-API-DMAC7.html)
BR112019016142A2 (cg-RX-API-DMAC7.html)
BR112021012348A2 (cg-RX-API-DMAC7.html)
AT524962A5 (cg-RX-API-DMAC7.html)
BR112021013128A2 (cg-RX-API-DMAC7.html)
BR112019016136A2 (cg-RX-API-DMAC7.html)
BR102019023359A2 (cg-RX-API-DMAC7.html)
BR102020025461B1 (pt) Dispositivo e processo de conversão de compostos aromáticos por alquilação de benzeno por etileno
BR102020020816B1 (pt) Veículo, e, método para controlar o movimento de ar através de um veículo com uma ventoinha do veículo
BR102020018650B1 (pt) Método para preparar óxido de cálcio usando um forno pré- aquecedor de suspensão de múltiplos estágios
BR102020017390B1 (pt) Bomba multifásica
BR102020016297B1 (pt) Bolsa de forro para um contentor e método para criar e prender uma bolsa de forro a um contentor
BR102020011722B1 (pt) Porta de tela para um pacote de radiadores
BR102020005984B1 (pt) Dispositivo de arranque-gerador combinado, e, conjunto de trem de acionamento
BR102020005860B1 (pt) Controle de obstrução para um implemento agrícola
BR112021010564B1 (pt) Sistema de armadilha para animais e método de monitoramento do mesmo
BR112021014592B1 (pt) Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas
BR112021013954B1 (pt) Sistema de cateter com confirmação da colocação do cateter dentro de uma veia
BR112021013470B1 (pt) Conector de acesso sem agulha para facilitar a entrega de instrumento a um conjunto de cateter
BR102020000355B1 (pt) Embreagem que tem dois estágios para aplicar torque variado entre um eixo de entrada e um eixo de saída
BR102019027339B1 (pt) Sistema de aspersão de água e difusor de sistema de aspersão de água
BR102019026575B1 (pt) Atuador, e, aeronave

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220421

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220421

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20220630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230314

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230530

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230829

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231129

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240213

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240307

R150 Certificate of patent or registration of utility model

Ref document number: 7456643

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150